Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Archives of Neurology

• Publication date

  2011-08-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1001/archneurol.2011.155PMID 21825236PMCID PMC3204798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

  2013cited by this paper
• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes.

  2010cited by this paper
• Validating Predicted Biological Effects of Alzheimer's Disease Associated SNPs Using CSF Biomarker Levels

  2010cited by this paper
• Genome-wide pathway analysis implicates intracellular transmembrane protein transport in Alzheimer disease

  2010cited by this paper
• S4‐03‐02: Genome‐Wide Association Study for Alzheimer's Disease Risk in a Large Cohort Of Clinically Characterized And Neuropathologically Verified Subjects

  2010cited by this paper
• SNPs Associated with Cerebrospinal Fluid Phospho-Tau Levels Influence Rate of Decline in Alzheimer's Disease

  2010cited by this paper
• Examination of the current top candidate genes for AD in a genome-wide association study

  2010cited by this paper
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes

  2009cited by this paper
• Genetic control of human brain transcript expression in Alzheimer disease.

  2009cited by this paper
• Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.

  2009cited by this paper
• Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

  2009cited by this paper
• A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease

  2009influential reference
• Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

  2009cited by this paper
• Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease

  2009cited by this paper
• Multiple rare SAPAP3 missense variants in trichotillomania and OCD

  2009cited by this paper
• Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition

  2008cited by this paper
• Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease.

  2008cited by this paper
• Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.

  2008cited by this paper
• Extreme cerebrospinal fluid amyloid β levels identify family with late‐onset Alzheimer's disease presenilin 1 mutation

  2007cited by this paper
• Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants.

  2007cited by this paper
• Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association.

  2007cited by this paper
• A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.

  2007cited by this paper
• GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.

  2007cited by this paper
• GAB2 Alleles Modify Alzheimer's Risk in APOE ε4 Carriers

  2007cited by this paper
• A survey of genetic human cortical gene expression

  2007cited by this paper
• Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.

  2007cited by this paper
• Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans

  2006cited by this paper
• Fluorescence-based fragment size analysis.

  2005cited by this paper
• A comparison of bayesian methods for haplotype reconstruction from population genotype data.

  2003cited by this paper
• Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

  1998influential reference
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper

• Geometrically Encoded Positioning of Introns, Intergenic Segments, and Exons in the Human Genome

  2025cites this paper
• Geometrically encoded positioning of introns, intergenic segments, and exons in the human genome

  2025cites this paper
• Molecular Mechanisms Linking Osteoarthritis and Alzheimer’s Disease: Shared Pathways, Mechanisms and Breakthrough Prospects

  2024cites this paper
• The Role of TOMM40 in Cardiovascular Mortality and Conduction Disorders: An Observational Study

  2024cites this paper
• Is the Relationship Between Cardiovascular Disease and Alzheimer’s Disease Genetic? A Scoping Review

  2024cites this paper
• Alzheimer's disease cortical morphological phenotypes are associated with TOMM40'523-APOE haplotypes.

  2023influential citation
• Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease

  2023cites this paper
• Neurobiology of Aging

  2023cites this paper
• Genotypic Effects of the TOMM40’523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW Study

  2023cites this paper
• Might Diet, APOE-APOA1 Axis, and Iron Metabolism Provide Clues About the Discrepancy in Alzheimer’s Disease Occurrence Between Humans and Chimpanzees? A Bioinformatics-Based Re-Analysis of Gene Expression Data on Mice Fed with Human and Chimpanzee Diets

  2023cites this paper
• The Current Landscape of Prevention Trials in Dementia

  2022cites this paper
• TOMM40 genetic variants associated with healthy aging and longevity: a systematic review

  2022cites this paper
• Genetically regulated expression in late-onset Alzheimer’s disease implicates risk genes within known and novel loci

  2021cites this paper
• TOMM40‐APOE haplotypes are associated with cognitive decline in non‐demented Blacks

  2021cites this paper
• Genetic predisposition to Alzheimer's disease

  2020cites this paper
• Folate-Dependent Cognitive Impairment Associated With Specific Gene Networks in the Adult Mouse Hippocampus

  2020cites this paper
• The TOMM40 ‘523’ polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson’s disease

  2020cites this paper
• Use of local genetic ancestry to assess TOMM40-523′ and risk for Alzheimer disease

  2020cites this paper
• A TOMM40/APOE allele encoding APOE‐E3 predicts high likelihood of late‐onset Alzheimer’s disease in autopsy cases

  2020cites this paper
• Genetická predispozice Alzheimerovy choroby Genetic predisposition to Alzheimer‘s disease

  2020cites this paper
• Detecting Shared Genetic Architecture Among Multiple Phenotypes by Hierarchical Clustering of Gene-Level Association Statistics

  2020cites this paper
• APOEɛ4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer’s Disease

  2020cites this paper
• A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward.

  2019cites this paper
• Detrimental and synergistic role of epilepsy – Alzheimer’s disease risk factors

  2019cites this paper
• PTCD1 Is Required for Mitochondrial Oxidative-Phosphorylation: Possible Genetic Association with Alzheimer's Disease

  2019cites this paper
• An APOE-independent cis-eSNP on chromosome 19q13.32 influences hippocampal structure, tau levels, and late-onset Alzheimer’s disease risk

  2018cites this paper
• Polygenic risk score of sporadic late‐onset Alzheimer's disease reveals a shared architecture with the familial and early‐onset forms

  2018cites this paper
• The effects of the TOMM40 poly‐T alleles on Alzheimer's disease phenotypes

  2018influential citation
• An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk.

  2018cites this paper
• Genome-wide significant risk factors on chromosome 19 and the APOE locus

  2018cites this paper
• Genetics of Human Longevity From Incomplete Data: New Findings From the Long Life Family Study

  2018cites this paper
• Biothiols and oxidative stress markers and polymorphisms of TOMM40 and APOC1 genes in Alzheimer’s disease patients

  2018cites this paper
• Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding

  2018cites this paper
• Selektive neuronale Vulnerabilität neurodegenerativer Erkrankungen am Beispiel des Thalamus

  2018cites this paper
• Epigenetic characterisation of ANK1, a novel gene implicated in Alzheimer’s disease (AD)

  2018cites this paper
• TOMM40′523 variant and cognitive decline in older persons with APOE ε3/3 genotype

  2017cites this paper
• Family history and TOMM40 '523 interactive associations with memory in middle‐aged and Alzheimer's disease cohorts

  2017cites this paper
• Title Hippocampal thinning linked to longer TOMM 40 poly-T variant lengths in the absence of the APOE epsilon 4 variant Permalink

  2017cites this paper
• Mitochondria, Cybrids, Aging, and Alzheimer's Disease.

  2017cites this paper
• Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer’s disease

  2017cites this paper
• Mild cognitive impairment due to Alzheimer disease: Contemporary approaches to diagnostics and pharmacological intervention

  2017cites this paper
• TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer’s Disease Subjects

  2017cites this paper
• Neuropathologic features of TOMM40 '523 variant on late‐life cognitive decline

  2017cites this paper
• The Alu neurodegeneration hypothesis: A primate-specific mechanism for neuronal transcription noise, mitochondrial dysfunction, and manifestation of neurodegenerative disease

  2017cites this paper
• VariFunNet, an integrated multiscale modeling framework to study the effects of rare non-coding variants in genome-wide association studies: Applied to Alzheimer's disease

  2017cites this paper
• Towards precision medicine in Alzheimer’s disease: deciphering genetic data to establish informative biomarkers

  2017cites this paper
• Lorazepam Challenge for Individuals at Varying Genetic Risk for Alzheimer Disease

  2017cites this paper
• Structural neuroimaging in preclinical dementia: From microstructural deficits and grey matter atrophy to macroscale connectomic changes.

  2017cites this paper
• Polygenic Risk Score of Sporadic late Onset Alzheimer Disease Reveals a Shared Architecture with the Familial and Early Onset Forms

  2017cites this paper
• Genetic and lifestyle influences on memory, brain structure, and dementia

  2017cites this paper
• Genetic Biomarkers in Alzheimer’s Disease

  2017cites this paper
• APOE ε4-TOMM40 ‘523 haplotypes and the risk of Alzheimer’s disease in older Caucasian and African Americans

  2017cites this paper
• Hippocampal thinning linked to longer TOMM40 poly‐T variant lengths in the absence of the APOE ε4 variant

  2017cites this paper
• Gene Interactions in the Pharmacogenomics of Alzheimer’s Disease

  2016cites this paper
• Associations between TOMM40 Poly-T Repeat Variants and Dementia in Cases with Parkinsonism

  2016cites this paper
• Altered Energy Metabolism Pathways in the Posterior Cingulate in Young Adult Apolipoprotein E ɛ4 Carriers

  2016cites this paper
• A genetics-based biomarker risk algorithm for predicting risk of Alzheimer's disease

  2016influential citation
• Genetic Investigations of Sporadic Inclusion Body Myositis and Myopathies with Structural Abnormalities and Protein Aggregates in Muscle

  2016cites this paper
• Featured Article A genetics-based biomarker risk algorithm for predicting risk of Alzheimer's disease

  2016cites this paper
• New Genetic Approaches to AD: Lessons from APOE-TOMM40 Phylogenetics

  2016cites this paper
• A TOMM40 poly-T variant modulates gene expression and is associated with vocabulary ability and decline in nonpathologic aging.

  2016cites this paper
• Elucidating novel dysfunctional pathways in Alzheimer's disease by integrating loci identified in genetic and epigenetic studies

  2016cites this paper
• Evaluation and management of patients with symptoms after anti-reflux surgery.

  2015cites this paper
• Homozygosity in the ApoE 4 polymorphism is associated with dysphagic symptoms in older adults.

  2015cites this paper
• Novel susceptibility loci for Alzheimer's disease.

  2015cites this paper
• Association of genetic variants with dyslipidemia.

  2015cites this paper
• 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

  2015cites this paper
• Blood Glucose Levels and Genetic Factors as Predictors of Neurocognitive Outcomes

  2015cites this paper
• Genetic susceptibility to accelerated cognitive decline in the US Health and Retirement Study.

  2014cites this paper
• The genetics of Alzheimer’s disease

  2014cites this paper
• Overrepresentation of Glutamate Signaling in Alzheimer's Disease: Network-Based Pathway Enrichment Using Meta-Analysis of Genome-Wide Association Studies

  2014cites this paper
• The Broad Impact of TOM40 on Neurodegenerative Diseases in Aging.

  2014cites this paper
• The genetics of Alzheimer’s disease

  2014cites this paper
• Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936

  2014cites this paper
• The Effect of TOMM40 Poly-T Repeat Lengths on Age of Onset and Cerebrospinal Fluid Biomarkers in Finnish Alzheimer's Disease Patients

  2014cites this paper
• The genetics of Alzheimer’s disease

  2014cites this paper
• The cis-regulatory effect of an Alzheimer ' s disease-associated poly-T locus on expression of TOMM 40 and APOE genes

  2014cites this paper
• Genetics and epigenetics in Parkinson´s disease

  2014cites this paper
• New applications of disease genetics and pharmacogenetics to drug development.

  2014cites this paper
• Genetics of Alzheimer's disease in Caribbean Hispanic and African American populations.

  2014influential citation
• The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes.

  2014influential citation
• The genetics of Alzheimer’s disease

  2014cites this paper
• The cis‐regulatory effect of an Alzheimer's disease‐associated poly‐T locus on expression of TOMM40 and apolipoprotein E genes

  2014cites this paper
• Missense variant in TREML2 protects against Alzheimer's disease

  2014cites this paper
• Atherosclerosis and Alzheimer - diseases with a common cause? Inflammation, oxysterols, vasculature

  2014cites this paper
• The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.

  2014cites this paper
• Genetics of Alzheimer's disease.

  2014cites this paper
• Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers

  2013cites this paper
• The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old age

  2013cites this paper
• Alzheimer’s Disease Susceptibility Genes APOE and TOMM40, and Hippocampal Volumes in the Lothian Birth Cohort 1936

  2013cites this paper
• TOMM40 intron 6 poly‐T length, age at onset, and neuropathology of AD in individuals with APOE ɛ3/ɛ3

  2013cites this paper
• Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease

  2013cites this paper
• GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.

  2013cites this paper
• TOMM40 and APOE: Requirements for replication studies of association with age of disease onset and enrichment of a clinical trial

  2013influential citation
• Missense variant in TREML 2 protects against Alzheimer ’ s Disease

  2013cites this paper
• Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms.

  2013cites this paper
• APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease.

  2013cites this paper
• Multilocus genetic profiling to empower drug trials and predict brain atrophy

  2013cites this paper
• The Impact of Mitochondrial DNA and Nuclear Genes Related to Mitochondrial Functioning on the Risk of Parkinson’s Disease

  2013cites this paper
• Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

  2013cites this paper